FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus

K Number: K213858 · Decision Jul 26, 2022
Classifications
1
FEI Numbers
10
Registration Numbers
10
Same Product Code
14
Applicant Total
71
Review Days
228

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus
K Number
K213858
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.5180
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
DiaSorin, Inc.
Date Received
December 10, 2021
Decision Date
July 26, 2022
Product Code
NXO
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NXO Calprotectin, Fecal

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NXO), ordered by most recent decision date.

View all

Other Clearances by DiaSorin, Inc.

K Number Device Name
K260770 LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX
DEN250032 LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261)
K231214 LIAISON VZV IgG HT, LIAISON Control VZV IgG HT
K223403 LIAISON Anti-HAV; LIAISON XS
K213936 LIAISON MeMed BV, LIAISON MeMed BV Control Set
K193650 LIAISON Ferritin
K202573 LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody Plus
K202574 LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody Plus
K210272 LIAISON Anti-HAV
K201908 LIAISON Testosterone xt
Search all 71 clearances from DiaSorin, Inc. →